KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Return on Invested Capital (2019 - 2025)

Vir Biotechnology's Return on Invested Capital history spans 7 years, with the latest figure at 0.01% for Q4 2025.

  • On a quarterly basis, Return on Invested Capital changed 0.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Invested Capital hit 0.01% in Q4 2025 for Vir Biotechnology, up from 0.01% in the prior quarter.
  • Over the last five years, Return on Invested Capital for VIR hit a ceiling of 0.01% in Q1 2022 and a floor of 0.01% in Q3 2025.
  • Historically, Return on Invested Capital has averaged 0.0% across 5 years, with a median of 0.0% in 2024.
  • Biggest five-year swings in Return on Invested Capital: rose 1bps in 2021 and later decreased -1bps in 2023.
  • Tracing VIR's Return on Invested Capital over 5 years: stood at 0.0% in 2021, then dropped by -21bps to 0.0% in 2022, then tumbled by -252bps to 0.0% in 2023, then decreased by -19bps to 0.0% in 2024, then dropped by -26bps to 0.01% in 2025.
  • Business Quant data shows Return on Invested Capital for VIR at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.